Search Within

David Hyman

Formats
  1. Meeting Abstract (174)
  2. Journal Article (170)
  3. Review (4)
  4. Research Letter (3)
  5. Editorial (2)
  6. Book Section (1)
Groups
  1. Department of Medicine (354)
  2. Early Drug Development Service (354)
  3. Solid Tumor Oncology Division (354)
  4. GSK Faculty (210)
  5. Department of Pathology and Laboratory Medicine (167)
  6. Human Oncology and Pathogenesis Program (167)

More Groups

People
  1. David Solit (107)
  2. Michael Berger (105)
  3. Marc Ladanyi (81)
  4. Alexander Drilon (78)
  5. Ahmet Zehir (75)
  6. Jose Baselga (68)

More People

Years
  1. 2024 (1)
  2. 2022 (4)
  3. 2021 (9)
  4. 2020 (44)
  5. 2019 (74)
  6. 2018 (57)

More Years

Publications
  1. Journal of Clinical Oncology (81)
  2. Cancer Research (32)
  3. Clinical Cancer Research (26)
  4. Annals of Oncology (22)
  5. Blood (19)
  6. Cancer Discovery (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (94)
  2. American Association for Cancer Research (82)
  3. Oxford University Press (26)
  4. Nature Publishing Group (23)
  5. American Society of Hematology (20)
  6. Elsevier Inc. (13)

More Publishers

Results (354)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective identification of potentially actionable molecular alterations in cancers of unknown primary
    Meeting Abstract

    Varghese, A. M.; Hyman, D. M.; Zehir, A.; Vakiani, E.; Klimstra, D. S.; Ladanyi, M.; Berger, M. F.; Solit, D. B.; Saltz, L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identifying actionable mutations in uterine leiomyosarcoma
    Meeting Abstract

    Soumerai, T.; Hyman, D. M.; Murali, R.; Zehir, A.; O'Cearbhaill, R. E.; Arcila, M. E.; Aghajanian, C.; Soslow, R. A.; Solit, D. B.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor relevant germline findings in targeted tumor sequencing using matched normal DNA of 1,570 unselected cases
    Meeting Abstract

    Schrader, K. A.; Cheng, D. T.; Vijai, J.; Prasad, M.; Walsh, M.; Zehir, A.; Thomas, T.; Benayed, R.; Stadler, Z. K.; Ashraf, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The clinical utility of ERBB2 amplification detection in breast carcinoma using a 341 gene hybrid capture-based next generation sequencing (NGS) assay: Comparison with standard immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) assays
    Meeting Abstract

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Nafa, K.; Jour, G.; Razavi, P.; Hyman, D. M.; Baselga, J.; Berger, M. F.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay
    Meeting Abstract

    Omuro, A. M. P.; Zehir, A.; Cheng, D. T.; Berger, M. F.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Ladanyi, M.; Arcila, M. E.; Hameed, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Carboplatin hypersensitivity reactions (HSR) in carboplatin retreatment for recurrent ovarian cancer
    Meeting Abstract

    O'Cearbhaill, R. E.; Hyman, D. M.; Tew, W. P.; Iasonos, A.; Cangemi, N. A.; Aghajanian, C.; Bell-Mcguinn, K. M.; Makker, V.; Hensley, M. L.; Konner, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I, first-in-human dose study of the dual PI3K/mTOR inhibitor LY3023414 (LY) in patients (pts) with advanced cancer
    Meeting Abstract

    Moore, K. N.; Varghese, A. M.; Hyman, D. M.; Callies, S.; Lin, J.; Wacheck, V.; Pant, S.; Bauer, T. M.; Bendell, J. C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-0231D)
    Meeting Abstract

    Hyman, D. M.; Sill, M.; Cho, J. K.; Lankes, H. A.; Piekarz, R.; Hensley, M. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Identification of novel and potentially targetable receptor tyrosine kinase alterations in colorectal carcinoma using a 341 gene hybrid capture-based next-generation sequencing assay
    Meeting Abstract

    Hechtman, J. F.; Arcila, M. E.; Cheng, D. T.; Solit, D. B.; Yaeger, R. D.; Hyman, D. M.; Berger, M. F.; Shia, J.; Vakiani, E.; Zehir, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save